Back to top
more

Shockwave Medical Inc. (SWAV)

(Delayed Data from NSDQ)

$43.43 USD

43.43
437,633

+2.29 (5.57%)

Updated May 3, 2019 04:00 PM ET

After-Market: $43.32 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Should You Buy ShockWave Medical (SWAV) Ahead of Earnings?

ShockWave Medical (SWAV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Shockwave Medical (SWAV) Crossed Above the 50-Day Moving Average: What That Means for Investors

Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?

Lantheus (LNTH) to Report Q3 Earnings: What's in the Cards?

Lantheus' (LNTH) third-quarter results are likely to reflect solid top-line performance on the back of robust product adoption.

Shockwave Medical (SWAV) Just Overtook the 20-Day Moving Average

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

Charles River (CRL) to Report Q3 Earnings: What's in Store?

Charles River's (CRL) CRADLE initiative and research models in North America and China are anticipated to have maintained their growth momentum in the third quarter.

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

What's in Store for Cardinal Health (CAH) in Q1 Earnings?

Cardinal Health's (CAH) first-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical segment.

Globus Medical (GMED) Earnings Expected to Grow: Should You Buy?

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stryker (SYK) to Report Q3 Earnings: Is a Beat in Store?

Stryker's (SYK) third-quarter 2023 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued hurting margins.

Cencora (COR) to Report Q4 Earnings: What's in the Cards?

Cencora's (COR) fiscal fourth-quarter 2023 results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.

Shockwave Medical (SWAV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Shockwave Medical (SWAV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is a Beat Likely for DENTSPLY SIRONA (XRAY) in Q3 Earnings?

DENTSPLY SIRONA's (XRAY) third-quarter 2023 results are likely to reflect a recovery in demand for consumable products, partially offset by lower sales in China due to volume-based procurement policy.

Baxter (BAX) to Report Q3 Earnings: Is a Beat in Store?

Baxter's (BAX) third-quarter results are likely to reflect growth in elective surgical procedures, offset by currency movement. Hillrom's products might have boosted sales.

Ecolab (ECL) to Report Q3 Earnings: What's in the Offing?

Ecolab's (ECL) third-quarter results are likely to reflect continued segmental strength.

Wall Street Analysts See a 27.54% Upside in Shockwave Medical (SWAV): Can the Stock Really Move This High?

The mean of analysts' price targets for Shockwave Medical (SWAV) points to a 27.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Integer (ITGR) Q3 Earnings and Revenues Top Estimates

Integer (ITGR) delivered earnings and revenue surprises of 20.95% and 8.71%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

NextGen (NXGN) Q2 Earnings Top Estimates, Margins Down

NextGen's (NXGN) second-quarter fiscal 2024 results reflect strength in its Recurring revenues.

Shockwave Medical (SWAV) Announces IVL Studies' Positive Results

Shockwave Medical's (SWAV) latest announcement of two new publications validates the utility of IVL in complex nodular and eccentric calcium.

Are Options Traders Betting on a Big Move in Shockwave Medical (SWAV) Stock?

Investors need to pay close attention to Shockwave Medical (SWAV) stock based on the movements in the options market lately.

Should Vanguard Russell 2000 ETF (VTWO) Be on Your Investing Radar?

Style Box ETF report for VTWO

Should Vanguard Russell 2000 Growth ETF (VTWG) Be on Your Investing Radar?

Style Box ETF report for VTWG

Is Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) a Strong ETF Right Now?

Smart Beta ETF report for JSMD

Shaun Pruitt headshot

3 Intriguing Stocks to Buy After Earnings

With various scenarios, these top-rated stocks are appealing after reporting their Q2 results on Monday and should have more upside as we progress through 2023.

Shockwave Medical (SWAV) Q2 Earnings Miss, Revenues Surge Y/Y

Shockwave Medical's (SWAV) second-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.